The new women's health and STI tests for the BD Max platform are part of a small, focused panel approach which the firm believes will resonate with physicians and labs.
The PCR-based panel tests for the pathogens that cause three types of gynecological infection: bacterial vaginosis, candidiasis, and trichomoniasis.
The method detected differences in the vaginal microbiome that matched up with patients' clinical diagnoses of vaginosis, and also their response to antibiotic treatment.
IMDx gets CE Mark for C. difficile assay on Abbott m2000; Medical Diagnostic Labs launches qPCR panel for bacterial vaginosis; Seegene introduces Anyplex plus MTB/NTM/DR-TB.
Illinois at Urbana-Champaign will lead an effort funded by NIAID to study bacterial metagenomics involved in women's genital tract infections.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.